Summary:
Experience with autologous bone marrow transplantation (ABMT) in patients with impaired left ventricular ejection fraction (LVEF) or heart failure (HF) is limited. We identified 308 consecutive patients who underwent ABMT for Hodgkin's or non-Hodgkin's lymphoma at our institution (1996–2003). Patient characteristics, clinical course and overall survival were compared between patients with preserved (⩾50%) or impaired (<50%) LVEF. Of the 308 patients identified, 20 had baseline impaired LVEF (four with LVEF ⩽40%, all NYHA class I–II HF). None of the patients with post-ABMT echocardiogram had worsened LVEF (n=7). Among the 20 patients with impaired LVEF, four patients had reversible cardiac complications post-ABMT (including worsening HF). The two deaths observed in the impaired LVEF group were both due to noncardiac causes. The 5-year survival was similar between patients with preserved and impaired LVEF (P=0.43). Careful selection of patients with stable, mild-to-moderate HF and impaired LVEF for ABMT can achieve similar long-term survival. As medical care for HF and ABMT improves, the exclusion criteria for ABMT with regard to HF and impaired LVEF should be re-examined.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Buja LM, Ferrans VJ, Graw RGJ . Cardiac pathologic findings in patients treated with bone marrow transplantation. Hum Pathol 1976; 7: 17–45.
Kupari M, Volin L, Suokas A et al. Cardiac involvement in bone marrow transplantation: electrocardiographic changes, arrhythmias, heart failure and autopsy findings. Bone Marrow Transplant 1990; 5: 91–98.
Cazin B, Gorin NC, Laporte JP et al. Cardiac complications after bone marrow transplantation: a report on a series of 63 consecutive transplantations. Cancer 1986; 57: 2061–2069.
Murdych T, Weisdorf DJ . Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977–1997. Bone Marrow Transplant 2001; 28: 283–287.
Fujimaki K, Maruta A, Yoshida M et al. Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction. Bone Marrow Transplant 2001; 27: 307–310.
Lehmann S, Isberg B, Ljungman P et al. Cardiac systolic function before and after hematopoietic stem cell transplantation. Bone Marrow Transplant 2000; 26: 187–192.
Bolwell BJ . Are predictive factors clinically useful in bone marrow transplantation? Bone Marrow Transplant 2003; 32: 853–861.
Bearman SI, Petersen FB, Schor RA . Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicity. Bone Marrow Transplant 1990; 5: 173–177.
Hetenstein B, Stefanic M, Schmeiser T . Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant. J Clin Oncol 1994; 12: 998–1004.
Jain B, Floreani AA, Anderson JR . Cardiopulmonary function and autologous bone marrow transplantation: results and predictive value for respiratory failure and mortality. Bone Marrow Transplant 1996; 17: 561–568.
Zangari M, Henzlova MJ, Ahmad S . Cardiopulmonary function and autologous bone marrow transplantation: results and predictive value for respiratory failure and mortality. Bone Marrow Transplant 1999; 23: 917–920.
Goldberg SL, Klumpp TR, Magdalinski AJ et al. Value of the pretransplant evaluation in predicting toxic day-100 mortality among blood stem-cell and bone marrow transplant recipients. J Clin Oncol 1998; 16: 3796–3802.
Brockstein BE, Smiley C, Al-Sadir J et al. Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors. Bone Marrow Transplant 2000; 25: 885–894.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tang, W., Thomas, S., Kalaycio, M. et al. Clinical outcomes of patients with impaired left ventricular ejection fraction undergoing autologous bone marrow transplantation: can we safely transplant patients with impaired ejection fraction?. Bone Marrow Transplant 34, 603–607 (2004). https://doi.org/10.1038/sj.bmt.1704610
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704610
Keywords
This article is cited by
-
Cardiovascular events among recipients of hematopoietic stem cell transplantation-A systematic review and meta-analysis
Bone Marrow Transplantation (2023)
-
Selection bias in follow-up studies of stem cell transplantation survivors: an experience within the Maastricht Observational study of late effects after Stem cell trAnsplantation (MOSA)
Annals of Hematology (2023)
-
Cardiovascular risk assessment and management of patients undergoing hematopoietic cell transplantation
Bone Marrow Transplantation (2021)
-
Cardiovascular disease and its management in children and adults undergoing hematopoietic stem cell transplantation
Journal of Thrombosis and Thrombolysis (2021)
-
Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value
Cancer Chemotherapy and Pharmacology (2017)